Global Canine Tumor Screening market size is predicted to grow from US$ 426 million in 2025 to US$ 666 million in 2032; it is expected to grow at a CAGR of 6.7% from 2026 to 2032.

Global Canine Tumor Screening Market Size, Share and Outlook 2026-32

The global Canine Tumor Screening market size is predicted to grow from US$ 426 million in 2025 to US$ 666 million in 2032; it is expected to grow at a CAGR of 6.7% from 2026 to 2032. Canine liquid biopsy is a method of analyzing biomarkers in body fluids (such as blood, urine or saliva) to detect the presence of cancer or monitor the progression of cancer. Unlike traditional tissue biopsies, liquid biopsies are non-invasive, fast and convenient. By obtaining a small blood sample, doctors can analyze free DNA, circulating tumor cells, exosomes, etc. to obtain information about the tumor. United States market for Canine Tumor Screening is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032. China market for Canine Tumor Screening is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032. Europe market for Canine Tumor Screening is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032. Global key Canine Tumor Screening players cover PetDx, CYTOGEN, BioChain, Small Door, ANGLE, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025. LPI (LP Information) newest research report, the Canine Tumor Screening Industry Forecast looks at past sales and reviews total world Canine Tumor Screening sales in 2025, providing a comprehensive analysis by region and market sector of projected Canine Tumor Screening sales for 2026 through 2032. With Canine Tumor Screening sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Canine Tumor Screening industry. This Insight Report provides a comprehensive analysis of the global Canine Tumor Screening landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Canine Tumor Screening portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Canine Tumor Screening market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Canine Tumor Screening and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Canine Tumor Screening. This report presents a comprehensive overview, market shares, and growth opportunities of Canine Tumor Screening market by product type, application, key players and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Cut Biopsy &nbsp;&nbsp;&nbsp; Needle Biopsy Segmentation by Application: &nbsp;&nbsp;&nbsp; Pet Hospital &nbsp;&nbsp;&nbsp; Clinic This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; PetDx &nbsp;&nbsp;&nbsp; CYTOGEN &nbsp;&nbsp;&nbsp; BioChain &nbsp;&nbsp;&nbsp; Small Door &nbsp;&nbsp;&nbsp; ANGLE &nbsp;&nbsp;&nbsp; BioChain Institute Inc. &nbsp;&nbsp;&nbsp; CANCAN DIAGNOSTICS.

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Canine Tumor Screening Market Size (2021-2032) &nbsp;2.1.2 Canine Tumor Screening Market Size CAGR by Region (2021 VS 2025 VS 2032) &nbsp;2.1.3 World Current & Future Analysis for Canine Tumor Screening by Country/Region (2021, 2025 & 2032) &nbsp;2.2 Canine Tumor Screening Segment by Type &nbsp;2.2.1 Cut Biopsy &nbsp;2.2.2 Needle Biopsy &nbsp;2.2.3 Canine Tumor Screening Market Size by Type &nbsp;2.2.3.1 Canine Tumor Screening Market Size CAGR by Type (2021 VS 2025 VS 2032) &nbsp;2.2.3.2 Global Canine Tumor Screening Market Size Market Share by Type (2021-2026) &nbsp;2.3 Canine Tumor Screening Segment by Application &nbsp;2.3.1 Pet Hospital &nbsp;2.3.2 Clinic &nbsp;2.3.3 Canine Tumor Screening Market Size by Application &nbsp;2.3.3.1 Canine Tumor Screening Market Size CAGR by Application (2021 VS 2025 VS 2032) &nbsp;2.3.3.2 Global Canine Tumor Screening Market Size Market Share by Application (2021-2026) 3 Canine Tumor Screening Market Size by Player &nbsp;3.1 Canine Tumor Screening Market Size Market Share by Player &nbsp;3.1.1 Global Canine Tumor Screening Revenue by Player (2021-2026) &nbsp;3.1.2 Global Canine Tumor Screening Revenue Market Share by Player (2021-2026) &nbsp;3.2 Global Canine Tumor Screening Key Players Head office and Products Offered &nbsp;3.3 Market Concentration Rate Analysis &nbsp;3.3.1 Competition Landscape Analysis &nbsp;3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026) &nbsp;3.4 New Products and Potential Entrants &nbsp;3.5 Mergers & Acquisitions, Expansion 4 Canine Tumor Screening by Region &nbsp;4.1 Canine Tumor Screening Market Size by Region (2021-2026) &nbsp;4.2 Global Canine Tumor Screening Annual Revenue by Country/Region (2021-2026) &nbsp;4.3 Americas Canine Tumor Screening Market Size Growth (2021-2026) &nbsp;4.4 APAC Canine Tumor Screening Market Size Growth (2021-2026) &nbsp;4.5 Europe Canine Tumor Screening Market Size Growth (2021-2026) &nbsp;4.6 Middle East & Africa Canine Tumor Screening Market Size Growth (2021-2026) 5 Americas &nbsp;5.1 Americas Canine Tumor Screening Market Size by Country (2021-2026) &nbsp;5.2 Americas Canine Tumor Screening Market Size by Type (2021-2026) &nbsp;5.3 Americas Canine Tumor Screening Market Size by Application (2021-2026) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Canine Tumor Screening Market Size by Region (2021-2026) &nbsp;6.2 APAC Canine Tumor Screening Market Size by Type (2021-2026) &nbsp;6.3 APAC Canine Tumor Screening Market Size by Application (2021-2026) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia 7 Europe &nbsp;7.1 Europe Canine Tumor Screening Market Size by Country (2021-2026) &nbsp;7.2 Europe Canine Tumor Screening Market Size by Type (2021-2026) &nbsp;7.3 Europe Canine Tumor Screening Market Size by Application (2021-2026) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Canine Tumor Screening by Region (2021-2026) &nbsp;8.2 Middle East & Africa Canine Tumor Screening Market Size by Type (2021-2026) &nbsp;8.3 Middle East & Africa Canine Tumor Screening Market Size by Application (2021-2026) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Global Canine Tumor Screening Market Forecast &nbsp;10.1 Global Canine Tumor Screening Forecast by Region (2027-2032) &nbsp;10.1.1 Global Canine Tumor Screening Forecast by Region (2027-2032) &nbsp;10.1.2 Americas Canine Tumor Screening Forecast &nbsp;10.1.3 APAC Canine Tumor Screening Forecast &nbsp;10.1.4 Europe Canine Tumor Screening Forecast &nbsp;10.1.5 Middle East & Africa Canine Tumor Screening Forecast &nbsp;10.2 Americas Canine Tumor Screening Forecast by Country (2027-2032) &nbsp;10.2.1 United States Market Canine Tumor Screening Forecast &nbsp;10.2.2 Canada Market Canine Tumor Screening Forecast &nbsp;10.2.3 Mexico Market Canine Tumor Screening Forecast &nbsp;10.2.4 Brazil Market Canine Tumor Screening Forecast &nbsp;10.3 APAC Canine Tumor Screening Forecast by Region (2027-2032) &nbsp;10.3.1 China Canine Tumor Screening Market Forecast &nbsp;10.3.2 Japan Market Canine Tumor Screening Forecast &nbsp;10.3.3 Korea Market Canine Tumor Screening Forecast &nbsp;10.3.4 Southeast Asia Market Canine Tumor Screening Forecast &nbsp;10.3.5 India Market Canine Tumor Screening Forecast &nbsp;10.3.6 Australia Market Canine Tumor Screening Forecast &nbsp;10.4 Europe Canine Tumor Screening Forecast by Country (2027-2032) &nbsp;10.4.1 Germany Market Canine Tumor Screening Forecast &nbsp;10.4.2 France Market Canine Tumor Screening Forecast &nbsp;10.4.3 UK Market Canine Tumor Screening Forecast &nbsp;10.4.4 Italy Market Canine Tumor Screening Forecast &nbsp;10.4.5 Russia Market Canine Tumor Screening Forecast &nbsp;10.5 Middle East & Africa Canine Tumor Screening Forecast by Region (2027-2032) &nbsp;10.5.1 Egypt Market Canine Tumor Screening Forecast &nbsp;10.5.2 South Africa Market Canine Tumor Screening Forecast &nbsp;10.5.3 Israel Market Canine Tumor Screening Forecast &nbsp;10.5.4 Turkey Market Canine Tumor Screening Forecast &nbsp;10.6 Global Canine Tumor Screening Forecast by Type (2027-2032) &nbsp;10.7 Global Canine Tumor Screening Forecast by Application (2027-2032) &nbsp;10.7.1 GCC Countries Market Canine Tumor Screening Forecast 11 Key Players Analysis &nbsp;11.1 PetDx &nbsp;11.1.1 PetDx Company Information &nbsp;11.1.2 PetDx Canine Tumor Screening Product Offered &nbsp;11.1.3 PetDx Canine Tumor Screening Revenue, Gross Margin and Market Share (2021-2026) &nbsp;11.1.4 PetDx Main Business Overview &nbsp;11.1.5 PetDx Latest Developments &nbsp;11.2 CYTOGEN &nbsp;11.2.1 CYTOGEN Company Information &nbsp;11.2.2 CYTOGEN Canine Tumor Screening Product Offered &nbsp;11.2.3 CYTOGEN Canine Tumor Screening Revenue, Gross Margin and Market Share (2021-2026) &nbsp;11.2.4 CYTOGEN Main Business Overview &nbsp;11.2.5 CYTOGEN Latest Developments &nbsp;11.3 BioChain &nbsp;11.3.1 BioChain Company Information &nbsp;11.3.2 BioChain Canine Tumor Screening Product Offered &nbsp;11.3.3 BioChain Canine Tumor Screening Revenue, Gross Margin and Market Share (2021-2026) &nbsp;11.3.4 BioChain Main Business Overview &nbsp;11.3.5 BioChain Latest Developments &nbsp;11.4 Small Door &nbsp;11.4.1 Small Door Company Information &nbsp;11.4.2 Small Door Canine Tumor Screening Product Offered &nbsp;11.4.3 Small Door Canine Tumor Screening Revenue, Gross Margin and Market Share (2021-2026) &nbsp;11.4.4 Small Door Main Business Overview &nbsp;11.4.5 Small Door Latest Developments &nbsp;11.5 ANGLE &nbsp;11.5.1 ANGLE Company Information &nbsp;11.5.2 ANGLE Canine Tumor Screening Product Offered &nbsp;11.5.3 ANGLE Canine Tumor Screening Revenue, Gross Margin and Market Share (2021-2026) &nbsp;11.5.4 ANGLE Main Business Overview &nbsp;11.5.5 ANGLE Latest Developments &nbsp;11.6 BioChain Institute Inc. &nbsp;11.6.1 BioChain Institute Inc. Company Information &nbsp;11.6.2 BioChain Institute Inc. Canine Tumor Screening Product Offered &nbsp;11.6.3 BioChain Institute Inc. Canine Tumor Screening Revenue, Gross Margin and Market Share (2021-2026) &nbsp;11.6.4 BioChain Institute Inc. Main Business Overview &nbsp;11.6.5 BioChain Institute Inc. Latest Developments &nbsp;11.7 CANCAN DIAGNOSTICS. &nbsp;11.7.1 CANCAN DIAGNOSTICS. Company Information &nbsp;11.7.2 CANCAN DIAGNOSTICS. Canine Tumor Screening Product Offered &nbsp;11.7.3 CANCAN DIAGNOSTICS. Canine Tumor Screening Revenue, Gross Margin and Market Share (2021-2026) &nbsp;11.7.4 CANCAN DIAGNOSTICS. Main Business Overview &nbsp;11.7.5 CANCAN DIAGNOSTICS. Latest Developments 12 Research Findings and Conclusion

Report	Global Canine Tumor Screening Market Trends, Growth and Opportunities 2026-32
Selected License	Multi ID: ILR2543

Buyer Information

Order Summary